We saw the opportunity to contribute both from the capital and experience, to accelerate the development and growth of biotechnology ventures in the region.

We saw the opportunity to contribute both from the capital and experience, to accelerate the development and growth of biotechnology ventures in the region.

Our team

The Zentynel Fund is managed by five partners. Each of them has extensive experience in the biotechnology sector, having developed and managed companies and/or investment funds in this industry.

With more than two decades of experience in investment and development of biotech companies, Cristián has been CEO, Director of Companies and Research Centers, such as Fundación Ciencia & Vida, Nova Mineralis, Ingalfarma, Phage Labs, among others.

linkedin LinkedIn

With over a decade of experience working in startup development, Pablo is a Director of the Alerce Fund and a board member of Andes Ag, GeneproDX, Done Properly, Polynatural, among other companies.

linkedin LinkedIn

With more than twenty years of experience in investment and development of alternative assets, Roberto is co-founder of Venturance Investments and member of the board of directors of Clínica Alemana de Santiago, Bbosch, Lippi and Streat Burger, among others.

linkedin LinkedIn

Bernardita has more than thirty years of experience in regulatory affairs and intellectual property in biomedical companies. She is president and co-founder of Fundación Ciencia y Vida. She also serves on the boards of Fundación Chile, Universidad Andrés Bello, Comunidad Mujer and other organizations.

linkedin LinkedIn

After more than four decades of investment and business development in the biotechnology industry, Pablo has developed many cutting-edge medical technologies, such as the hepatitis B vaccine. He co-founded Chiron Corporation in 1982, one of the industry’s early pioneers in genetic engineering. In 2005, his company was acquired by Novartis for $8.9 billion.

With more than two decades of experience in investment and development of biotech companies, Cristián has been CEO, Director of Companies and Research Centers, such as Fundación Ciencia & Vida, Nova Mineralis, Ingalfarma, Phage Labs, among others.

linkedin LinkedIn

With over a decade of experience working in startup development, Pablo is a Director of the Alerce Fund and a board member of Andes Ag, GeneproDX, Done Properly, Polynatural, among other companies.

linkedin LinkedIn

With more than twenty years of experience in investment and development of alternative assets, Roberto is co-founder of Venturance Investments and member of the board of directors of Clínica Alemana de Santiago, Bbosch, Lippi and Streat Burger, among others.

linkedin LinkedIn

Bernardita has more than thirty years of experience in regulatory affairs and intellectual property in biomedical companies. She is president and co-founder of Fundación Ciencia y Vida. She also serves on the boards of Fundación Chile, Universidad Andrés Bello, Comunidad Mujer and other organizations.

linkedin LinkedIn

After more than four decades of investment and business development in the biotechnology industry, Pablo has developed many cutting-edge medical technologies, such as the hepatitis B vaccine. He co-founded Chiron Corporation in 1982, one of the industry’s early pioneers in genetic engineering. In 2005, his company was acquired by Novartis for $8.9 billion.

linkedin LinkedIn

Unparalleled Advisors

We are advised by a team of specialists in listed biomedical companies, corporate finance, digital health, and big data, who complement our experience with deep knowledge and powerful networks.

Les Funtleyder |

Investment Manager at E Squared Capital, Investment Fund in New York

Responsible for leading the fundamental analysis and valuations of public and private companies in the Health industry. Author of the book “Healthcare Investing”

Juan Andrés Camus |

President of the Santiago Stock Exchange, co-founder of Celfin Capital

Responsible for having consolidated Celfin Capital as the iconic investment banking company in Chile. Director of several companies and NGOs in Chile and abroad.

Henrique Martins |

Physician (internist), with a Master's and Doctorate in Management (Cambridge University) and other postgraduate degrees in HIV and Law

He was president of the eHealth Services of the Portuguese Ministry of Health for more than 7 years and led all joint action efforts of the European Community to implement eHealth.

César Hidalgo |

Visiting Professor at the Harvard School of Engineering and Applied Sciences

Founder of Data wheel distribution and visualization company data. It received the Lagrange award in 2018.

Unparalleled Advisors

We are advised by a team of specialists in listed biomedical companies, corporate finance, digital health, and big data, who complement our experience with deep knowledge and powerful networks.

Les Funtleyder

Investment Manager at E Squared Capital, Investment Fund in New York

Responsible for leading the fundamental analysis and valuations of public and private companies in the Health industry. Author of the book “Healthcare Investing”

Juan Andrés Camus

President of the Santiago Stock Exchange, co-founder of Celfin Capital

Responsible for having consolidated Celfin Capital as the iconic investment banking company in Chile. Director of several companies and NGOs in Chile and abroad.

Henrique Martins

Physician (internist), with a Master's and Doctorate in Management (Cambridge University) and other postgraduate degrees in HIV and Law

He was president of the eHealth Services of the Portuguese Ministry of Health for more than 7 years and led all joint action efforts of the European Community to implement eHealth.

César Hidalgo

Visiting Professor at the Harvard School of Engineering and Applied Sciences

Founder of Data wheel distribution and visualization company data. It received the Lagrange award in 2018.